Inhibitors of tyrosine kinases
US7169791B2 · kind B2 · utility
60Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 4, 2003 |
| Grant date | Jan 30, 2007 |
| Priority date | — |
| Expiry date | Jul 4, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of formulawherein the substituents R1, R2 and R4 have the meaning as set forth and explained in the description of the invention, to processes for the preparation of these compounds, pharmaceutical compositions containing same, the use thereof optionally in combination with one or more other pharmaceutically active compounds for the therapy of a disease which responds to an inhibition of protein kinase activity, especially a neoplastic disease, in particular leukaemia, and a method for the treatment of such a disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.